1
|
Comparison of Gene Expression Patterns in Articular Cartilage and Xiphoid Cartilage. Biochem Genet 2021; 60:676-706. [PMID: 34410558 DOI: 10.1007/s10528-021-10127-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2021] [Accepted: 08/13/2021] [Indexed: 10/20/2022]
Abstract
Cartilage is a resilient and smooth connective tissue that is found throughout the body. Among the three major types of cartilage, namely hyaline cartilage, elastic cartilage, and fibrocartilage, hyaline cartilage is the most widespread type of cartilage predominantly located in the joint surfaces (articular cartilage, AC). It remains a huge challenge for orthopedic surgeons to deal with AC damage since it has limited capacity for self-repair. Xiphoid cartilage (XC) is a vestigial cartilage located in the distal end of the sternum. XC-derived chondrocytes exhibit strong chondrogenic differentiation capacity. Thus, XC could become a potential donor site of chondrocytes for cartilage repair and regeneration. However, the underlying gene expression patterns between AC and XC are still largely unknown. In the present study, we used state-of-the-art RNA-seq technology combined with validation method to investigate the gene expression patterns between AC and XC, and identified a series of differentially expressed genes (DEGs) involved in chondrocyte commitment and differentiation including growth factors, transcription factors, and extracellular matrices. We demonstrated that the majority of significantly up-regulated DEGs (XC vs. AC) in XC were involved in regulating cartilage regeneration and repair, whereas the majority of significantly up-regulated DEGs (XC vs. AC) in AC were involved in regulating chondrocyte differentiation and maturation. This study has increased our knowledge of transcriptional networks in hyaline cartilage and elastic cartilage. It also supports the use of XC-derived chondrocytes as a potential cell resource for cartilage regeneration and repair.
Collapse
|
2
|
Feliksiak K, Solarz D, Guzik M, Zima A, Rajfur Z, Witko T. Vimentin Cytoskeleton Architecture Analysis on Polylactide and Polyhydroxyoctanoate Substrates for Cell Culturing. Int J Mol Sci 2021; 22:6821. [PMID: 34201927 PMCID: PMC8268722 DOI: 10.3390/ijms22136821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2021] [Revised: 06/21/2021] [Accepted: 06/23/2021] [Indexed: 11/16/2022] Open
Abstract
Polylactide (PLA), widely used in bioengineering and medicine, gained popularity due to its biocompatibility and biodegradability. Natural origin and eco-friendly background encourage the search of novel materials with such features, such as polyhydroxyoctanoate (P(3HO)), a polyester of bacterial origin. Physicochemical features of both P(3HO) and PLA have an impact on cellular response 32, i.e., adhesion, migration, and cell morphology, based on the signaling and changes in the architecture of the three cytoskeletal networks: microfilaments (F-actin), microtubules, and intermediate filaments (IF). To investigate the role of IF in the cellular response to the substrate, we focused on vimentin intermediate filaments (VIFs), present in mouse embryonic fibroblast cells (MEF). VIFs maintain cell integrity and protect it from external mechanical stress, and also take part in the transmission of signals from the exterior of the cell to its inner organelles, which is under constant investigation. Physiochemical properties of a substrate have an impact on cells' morphology, and thus on cytoskeleton network signaling and assembly. In this work, we show how PLA and P(3HO) crystallinity and hydrophilicity influence VIFs, and we identify that two different types of vimentin cytoskeleton architecture: network "classic" and "nutshell-like" are expressed by MEFs in different numbers of cells depending on substrate features.
Collapse
Affiliation(s)
- Karolina Feliksiak
- Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, 30-348 Cracow, Poland; (K.F.); (D.S.)
| | - Daria Solarz
- Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, 30-348 Cracow, Poland; (K.F.); (D.S.)
| | - Maciej Guzik
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, 30-239 Cracow, Poland;
| | - Aneta Zima
- Faculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Cracow, Poland;
| | - Zenon Rajfur
- Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, 30-348 Cracow, Poland; (K.F.); (D.S.)
- Jagiellonian Center of Biomedical Imaging, Jagiellonian University, 30-348 Cracow, Poland
| | - Tomasz Witko
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, 30-239 Cracow, Poland;
| |
Collapse
|
3
|
Tu JH, Piao YS, Lu DH, Wang LM, Liu L, Bai DY, Han HW, Lin YK, Zhong S. An adult case of diffuse midline glioma with H3 K27M mutation. Neuropathology 2020; 40:627-631. [PMID: 32954563 DOI: 10.1111/neup.12689] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2020] [Revised: 04/15/2020] [Accepted: 05/14/2020] [Indexed: 11/30/2022]
Abstract
Cartilaginous metaplasia is rare in primary central nervous system (CNS) neoplasms and has not been described in the histone 3 (H3) gene (H3) with a substitution of lysine to methionine (H3 K27M mutant) diffuse midline glioma before. Here, we report a case of H3 K27M mutant diffuse midline glioma with cartilaginous metaplasia in a 56-year-old woman. Magnetic resonance imaging (MRI) revealed a ring-enhanced lesion located in the medulla oblongata and extended superiorly into the fourth ventricle. The tumor was macroscopically completely resected. Histologically, the tumor was composed of a gliomatous component and a well-differentiated cartilaginous component. Microvascular proliferation and necrosis were noted. According to immunohistochemical staining, glial cells were diffusely and strongly positive for glial fibrillary acidic protein (GFAP), oligodendrocyte lineage transcription factor 2 (Olig2), H3 K27M, and S-100 protein but negative for H3K27me3. The chondrocytes also were positive for GFAP and S-100 protein. The H3 K27M mutation was confirmed by sequencing in both the gliomatous and cartilaginous components, suggesting a common origin from the same progenitor cells. Based on these findings, the tumor was diagnosed as a diffuse midline glioma with H3 K27M mutation with widespread cartilaginous metaplasia, corresponding to WHO grade IV. This is an extremely rare H3 K27M mutant diffuse midline glioma with cartilaginous metaplasia, and reporting this unusual case adds to the understanding of this tumor type.
Collapse
Affiliation(s)
- Jin-Hua Tu
- Department of Pathology, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Yue-Shan Piao
- Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - De-Hong Lu
- Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Lei-Ming Wang
- Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Li Liu
- Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Dong-Yu Bai
- Department of Pathology, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Hai-Wei Han
- Department of Radiology, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Yi-Kai Lin
- Department of Radiology, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Shan Zhong
- Department of Pathology, The First Affiliated Hospital of Xiamen University, Xiamen, China
| |
Collapse
|
4
|
Nishizawa S, Kanazawa S, Fujihara Y, Asawa Y, Nagata S, Harai M, Hikita A, Takato T, Hoshi K. Glial Fibrillary Acidic Protein as Biomarker Indicates Purity and Property of Auricular Chondrocytes. Biores Open Access 2020; 9:51-63. [PMID: 32140296 PMCID: PMC7057647 DOI: 10.1089/biores.2019.0058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Instead of the silicone implants previously used for repair and reconstruction of the auricle and nose lost due to accidents and disease, a new treatment method using tissue-engineered cartilage has been attracting attention. The quality of cultured cells is important in this method because it affects treatment outcomes. However, a marker of chondrocytes, particularly auricular chondrocytes, has not yet been established. The objective of this study was to establish an optimal marker to evaluate the quality of cultured auricular chondrocytes as a cell source of regenerative cartilage tissue. Gene expression levels were comprehensively compared using the microarray method between human undifferentiated and dedifferentiated auricular chondrocytes to investigate a candidate quality control index with an expression level that is high in differentiated cells, but markedly decreases in dedifferentiated cells. We identified glial fibrillary acidic protein (GFAP) as a marker that decreased with serial passages in auricular chondrocytes. GFAP was not detected in articular chondrocytes, costal chondrocytes, or fibroblasts, which need to be distinguished from auricular chondrocytes in cell cultures. GFAP mRNA expression was observed in cultured auricular chondrocytes, and GFAP protein levels were also measured in the cell lysates and culture supernatants of these cells. However, GFAP levels detected from mRNA and protein in cell lysates were significantly decreased by increases in the incubation period. In contrast, the amount of protein in the cell supernatant was not affected by the incubation period. Furthermore, the protein level of GFAP in the supernatants of cultured cells correlated with the in vitro and in vivo production of the cartilage matrix by these cells. The productivity of the cartilage matrix in cultured auricular chondrocytes may be predicted by measuring GFAP protein levels in the culture supernatants of these cells. Thus, GFAP is regarded as a marker of the purity and properties of cultured auricular chondrocytes.
Collapse
Affiliation(s)
- Satoru Nishizawa
- Translational Research Center, The University of Tokyo Hospital, Tokyo, Japan
| | - Sanshiro Kanazawa
- Department of Cell and Tissue Engineering (Fujisoft) and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Yuko Fujihara
- Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Yukiyo Asawa
- Department of Cell and Tissue Engineering (Fujisoft) and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Satoru Nagata
- NAGATA Microtia and Reconstructive Plastic Surgery Clinic, Toda City, Japan
| | - Motohiro Harai
- FUJISOFT Tissue Engineering Co., Ltd., Yokohama-shi, Japan
| | - Atsuhiko Hikita
- Department of Cell and Tissue Engineering (Fujisoft) and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Tsuyoshi Takato
- Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Kazuto Hoshi
- Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| |
Collapse
|
5
|
Harata M, Watanabe M, Nagata S, Ko EC, Ohba S, Takato T, Hikita A, Hoshi K. Improving chondrocyte harvests with poly(2-hydroxyethyl methacrylate) coated materials in the preparation for cartilage tissue engineering. Regen Ther 2017; 7:61-71. [PMID: 30271853 PMCID: PMC6149190 DOI: 10.1016/j.reth.2017.08.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Revised: 08/07/2017] [Accepted: 08/14/2017] [Indexed: 11/07/2022] Open
Abstract
Remarkable advances have been made in cartilage regenerative medicine to cure congenital anomalies including microtia, tissue defects caused by craniofacial injuries, and geriatric diseases such as osteoarthritis. However, those procedures require a substantial quantity of chondrocytes for tissue engineering. Previous studies have required several passages to obtain sufficient cell numbers for three-dimensional and monolayer cultures. Thus, our objective was to improve the quantity of chondrocytes that can be obtained by examining an anti-fouling polyhydrophilic chemical called poly(2-hydroxyethyl methacrylate) (pHEMA). To determine the effectiveness of the chemical, pHEMA solution was applied via dip-coating to centrifuge tubes, serological pipettes, and pipette tips. The cell quantity obtained during standard cell culturing and passaging procedures was measured alongside non-coated materials as a control. A significant 2.2-fold increase of chondrocyte yield was observed after 2 passages when pHEMA was applied to the tubes compared to when non-coated tubes were utilized. The 3-dimensional chondrocyte pellets prepared from the respective cell populations and transplanted into nude mice were histologically and biochemically analyzed. No evidence of difference in matrix production for in vitro and in vivo cultures was found as well as similar proliferation rates and colony formation abilities. The use of pHEMA provides a powerful alternative method for expanding the quantity of chondrocytes harvested and handled during cell isolation and passaging to enhance cartilage tissue engineering.
Collapse
Affiliation(s)
- Mikako Harata
- Division of Tissue Engineering, The University of Tokyo Hospital, Tokyo, Japan
- Department of Oral-maxillofacial Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Makoto Watanabe
- Division of Tissue Engineering, The University of Tokyo Hospital, Tokyo, Japan
| | - Satoru Nagata
- Nagata Microtia and Reconstructive Plastic Surgery Clinic, Saitama, Japan
| | | | - Shinsuke Ohba
- Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan
| | - Tsuyoshi Takato
- Division of Tissue Engineering, The University of Tokyo Hospital, Tokyo, Japan
- Department of Oral-maxillofacial Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Atsuhiko Hikita
- Division of Tissue Engineering, The University of Tokyo Hospital, Tokyo, Japan
| | - Kazuto Hoshi
- Division of Tissue Engineering, The University of Tokyo Hospital, Tokyo, Japan
- Department of Oral-maxillofacial Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| |
Collapse
|